Skip to main content
SpringerLink
Log in

Pulmonary Delivery of Peptide Drugs: Effect of Particle Size on Bioavailability of Leuprolide Acetate in Healthy Male Volunteers

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Leuprolide acetate, a nonapeptide with potent luteinizing hormone releasing hormone (LHRH) agonist activity, has low oral bioavailability. Unique aerosols of leuprolide acetate were developed and particle size distribution studies were carried out. A light scattering method (Malvern Model 2600c) was compared to the impaction method (Andersen Sampler) for measuring size distribution. Results showed the Malvern method to be comparable to the impaction method with the Malvern being faster and easier to use. Absolute bioavailability of leuprolide acetate in healthy human male volunteers ranged from 4% to 18% and agreed well with particle size data. Bioavailability corrected for respirable fraction ranged from 35% to 55%, indicating that the pulmonary route may have high potential for systemic delivery of this peptide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. A. V. Schally, A. J. Kastin, and A. Arimura. Fertil. Steril. 22:703–721 (1971).

    Google Scholar 

  2. M. M. Garnick and other participants including D. T. Max from Abbott. N. Engl. J. Med. 311:1281–1286 (1984).

    Google Scholar 

  3. D. R. Meldrum, R. J. Chang, J. Lu, W. Vale, J. Rivier, and H. L. Judo. J. Clin. Endocrinol. Metab. 54:1081–1083 (1982).

    Google Scholar 

  4. A. Lemay, R. Maleux, N. Faure, C. Jean, and A. T. A. Fazekas. J. Steroid Biochem. 20(N6B):1379 (1984).

    Google Scholar 

  5. D. H. Bowden. Environ. Lung Res. 12:89–107 (1987).

    Google Scholar 

  6. D. Ganderton and T. M. Jones. Drug Delivery to the Respiratory Tract. Ellis Norwood Series in Biomedicine (1987), Chap. 1.

  7. R. N. Dalby and P. Byron. Pharm. Res. 5(1):36–39 (1988).

    Google Scholar 

  8. G. W. Hallworth and D. G. Westmoreland. J. Pharm. Pharmacol. 39:966–972 (1987).

    Google Scholar 

  9. J. W. Sutherland and G. N. Menon. J. Liq. Chromatogr. 10(10):2281–2289 (1987).

    Google Scholar 

  10. I. Yamazaki and H. Okada. J. Endocrinol. Japon. 27:593–605 (1980).

    Google Scholar 

  11. C. M. Metzler, G. L. Elfring, and A. J. McEwen. Biometrics 30:562–563 (1974).

    Google Scholar 

  12. P. R. Byron, S. S. Davis, M. D. Bubb, and P. Cooper. Pestic. Sci. 8:521–526 (1977).

    Google Scholar 

  13. A. J. Hickey. Drug Dev. Ind. Pharm. 14:337–352 (1988).

    Google Scholar 

  14. H. Okada, I. Yamazaki, Y. Ogawa, S. Hirai, T. Yashiki, and H. Mima. J. Pharm. Sci. 71:1367–1371 (1982).

    Google Scholar 

  15. V. H. Lee. In S. S. Davis, L. Illum, and E. Tomlinson (eds.), Delivery Systems for Peptide Drugs, Plenum Press, New York, 1986, pp. 87–104.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmaceutics and Liquid Products Development, Abbott Laboratories, 1400 Sheridan Road, North-Chicago, Illinois, 60064

    Akwete Adjei & Julie Garren

Authors
  1. Akwete Adjei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julie Garren
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adjei, A., Garren, J. Pulmonary Delivery of Peptide Drugs: Effect of Particle Size on Bioavailability of Leuprolide Acetate in Healthy Male Volunteers. Pharm Res 7, 565–569 (1990). https://doi.org/10.1023/A:1015853824722

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015853824722

Search

Navigation